IQ's First Decade: Reflections from IQ Leaders

The IQ Consortium marked its 10th anniversary in 2020. In IQ's First Decade: Reflections from IQ Leaders, IQ leaders from 2010 to present share their perspectives on the impact brought to the global pharmaceutical industry by IQ initiatives and the value of the IQ consortium’s collaborative environment. 


Terry Tougas, PhD

TERRY TOUGAS, PhD  
IQ Board of Directors Chair (2010-2012)

Highly Distinguished Research Fellow
Boehringer Ingelheim (Ret.)

Lewis Kinter, PhD

LEWIS KINTER, PhD, DABT, FATS   
IQ Board of Directors Chair (2012-2014)
Senior Director, Regulatory Toxicology
AstraZeneca (Ret.)

MARGARET FAUL, PhD
IQ Board of Directors Chair (2021-2023)
Vice President, Drug Product Technologies 
Amgen

Michael Garvin, PhD

MICHAEL GARVIN, PharmD
IQ Board of Directors Member(2014-Present)
Senior Director, Regulatory Policy
AstraZeneca

Douglas Keller, PhD

DOUG KELLER, PhD
IQ Board of Directors Member (2010-2020)
Global Head for Development Projects, Preclinical Safety
Sanofi (Ret.)

 

Nancy Agrawal, PhD

NANCY AGRAWAL, PhD
IQ Translational and ADME Sciences Leadership Group (2013-Present)

Vice President, Pharmacokinetics, Pharmacodynamics,
Drug Metabolism (PPDM)
Merck & Co., Inc.

Akintunde

TUNDE BELLO, PhD
IQ Clinical Pharmacology Leadership Group (2012-Present)
Vice President, Clinical Pharmacology and Pharmacometrics
Bristol Myers Squibb

 

Timothy JN Watson, PhD 

TIM WATSON, PhD
IQ Board of Directors Vice Chair (2021-2023)
Executive Director/Leader of the Global CMC Advisory Office
Pfizer

 

SANDHYA GIRISH, PhD
IQ Clinical Pharmacology Leadership Group (CPLG) (2016-Present)
Vice President, Clinical Pharmacology
Gilead

MICHAEL GRAZIANO, PhD
IQ Board of Directors Member (2021-Present)
Associate Vice President, Preclinical Development
Organon LLC

JOHN BURKHARDT, PhD, DVM
IQ Board of Directors Member (2018-2021)
Senior Vice President - Global Head, Drug Safety R&D
Pfizer

 

CARL McMILLIAN, PhD
IQ Board of Directors Chair (2018-2020)

Vice President, Toxicology, Drug Disposition, PKPD
Eli Lilly and Company

THOMAS MONTICELLO, PhD, DVM, DIPLOMATE OF ACVP
IQ Board of Directors Chair (2015-Present)
Executive Director
Amgen

 

 

ROBERT TERNIK, PhD
IQ Drug Product Leadership Group (DPLG)  (2012-Present)
Sr. Research Advisor and Design Team Leader
Eli Lilly and Company

DENNIS O’CONNOR
IQ Consortium Board of Directors Member (2018-2021)
Senior Associate Director, GMP QA
Boehringer Ingelheim (Ret.)

 

 

MAGGIE LIU, PhD
IQ DruSafe (2017-Present)
Director
Pfizer

VIKRAM SINHA, PhD, FACP
IQ Clinical Pharmacology Leadership Group (CPLG) (2017-Present)
Vice President, Global Head Quantitative Clinical Pharmacology
Takeda

 

TIMOTHY CURRAN, PhD
IQ Board of Directors Member (2019-Present)
Senior Director
Vertex

DONNA CLEMONS, DVM, MS. DACLAM
IQ 3Rs Translational and Predictive Sciences Leadership Group (3Rs TPS) (2012-Present)
Global Director Comparative Medicine, AbbVie